Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

NCT05329961 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

155

Enrollment

OTHER

Sponsor class

Conditions

Human Papilloma Virus

Interventions

DRUG: Gardasil9

Sponsor

Boston Medical Center

Collaborators

[object Object]